复发性胶质母细胞瘤-话题@MedSci

#复发性胶质母细胞瘤#

13篇内容 | 669人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1537096, encodeId=224c153e0968e, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤的疗效, objectType=article, longId=295055, objectId=f6e229505515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e229505515, replyNumber=0, likeNumber=37, createdTime=2022-02-04, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e229505515, moduleTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e229505515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537095, encodeId=a70d153e0955f, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, objectType=article, longId=292166, objectId=891e29216606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891e29216606, replyNumber=0, likeNumber=33, createdTime=2021-12-19, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891e29216606, moduleTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=891e29216606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537094, encodeId=c2ed153e09441, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, objectType=article, longId=292164, objectId=e7c829216496, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7c829216496, replyNumber=0, likeNumber=40, createdTime=2021-12-19, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7c829216496, moduleTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7c829216496)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537093, encodeId=21fa153e0934c, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, objectType=article, longId=220476, objectId=41ac2204e60d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ac2204e60d, replyNumber=0, likeNumber=42, createdTime=2021-11-18, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ac2204e60d, moduleTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ac2204e60d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537092, encodeId=a5a1153e09217, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, objectType=article, longId=220259, objectId=ae6b22025996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6b22025996, replyNumber=0, likeNumber=33, createdTime=2021-11-14, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6b22025996, moduleTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6b22025996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537091, encodeId=a42f153e091c7, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Br J Cancer：替莫唑胺与nabiximols大麻素喷雾治疗复发性胶质母细胞瘤的安全性和疗效分析, objectType=article, longId=207578, objectId=ad9320e578f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9320e578f7, replyNumber=0, likeNumber=51, createdTime=2021-02-26, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9320e578f7, moduleTitle=Br J Cancer：替莫唑胺与nabiximols大麻素喷雾治疗复发性胶质母细胞瘤的安全性和疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9320e578f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537090, encodeId=daf2153e09026, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=NMPA批准BYVASDA（贝伐单抗生物仿制药）治疗复发性胶质母细胞瘤, objectType=article, longId=205139, objectId=3675205139af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3675205139af, replyNumber=0, likeNumber=35, createdTime=2021-01-02, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3675205139af, moduleTitle=NMPA批准BYVASDA（贝伐单抗生物仿制药）治疗复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3675205139af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537089, encodeId=8c13153e089cc, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=微生物组疗法治疗癌症！复发性胶质母细胞瘤的治疗或迎来新希望, objectType=article, longId=198451, objectId=611b1984514b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=611b1984514b, replyNumber=0, likeNumber=43, createdTime=2020-08-01, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=611b1984514b, moduleTitle=微生物组疗法治疗癌症！复发性胶质母细胞瘤的治疗或迎来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=611b1984514b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537088, encodeId=cf18153e088d8, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=2019年神经肿瘤学会：IL-12治疗复发性胶质母细胞瘤的临床数据, objectType=article, longId=183565, objectId=c2ab183565aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2ab183565aa, replyNumber=0, likeNumber=32, createdTime=2019-11-26, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2ab183565aa, moduleTitle=2019年神经肿瘤学会：IL-12治疗复发性胶质母细胞瘤的临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2ab183565aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537087, encodeId=9225153e08761, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=Lancet oncol：瑞戈非尼可提高复发性胶质母细胞瘤患者总体存活率（REGOMA研究）, objectType=article, longId=155411, objectId=cdda15541182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdda15541182, replyNumber=0, likeNumber=48, createdTime=2018-12-10, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdda15541182, moduleTitle=Lancet oncol：瑞戈非尼可提高复发性胶质母细胞瘤患者总体存活率（REGOMA研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdda15541182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537086, encodeId=cef2153e086c3, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=NEJM：重组脊髓灰质炎病毒治疗复发性胶质母细胞瘤, objectType=article, longId=141847, objectId=9b3814184ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b3814184ef0, replyNumber=0, likeNumber=43, createdTime=2018-06-30, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3814184ef0, moduleTitle=NEJM：重组脊髓灰质炎病毒治疗复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b3814184ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537085, encodeId=7d3b153e085a3, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=ASCO2017 ：VEGFR2 单抗用于复发性胶质母细胞瘤, objectType=article, longId=100862, objectId=d667100862d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d667100862d8, replyNumber=0, likeNumber=30, createdTime=2017-06-08, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d667100862d8, moduleTitle=ASCO2017 ：VEGFR2 单抗用于复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d667100862d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537084, encodeId=411d153e084ed, content=<a href='/topic/show?id=48274255263' target=_blank style='color:#2F92EE;'>#复发性胶质母细胞瘤#</a>, objectTitle=J Neurooncol：重大突破！基因疗法可使复发性胶质母细胞瘤患者的存活期翻倍, objectType=article, longId=56904, objectId=55fe569046c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fe569046c, replyNumber=0, likeNumber=39, createdTime=2015-10-07, rootId=0, userName=charl1234571, userId=d61112794032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fe569046c, moduleTitle=J Neurooncol：重大突破！基因疗法可使复发性胶质母细胞瘤患者的存活期翻倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fe569046c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性胶质母细胞瘤

2020-05-29

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤的疗效

2022-02-04

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性

2021-12-19

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤

2021-12-19

hb2008ye (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性

2021-11-18

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤

2021-11-14

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Br J Cancer：替莫唑胺与nabiximols大麻素喷雾治疗复发性胶质母细胞瘤的安全性和疗效分析

2021-02-26

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

NMPA批准BYVASDA（贝伐单抗生物仿制药）治疗复发性胶质母细胞瘤

2021-01-02

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

微生物组疗法治疗癌症！复发性胶质母细胞瘤的治疗或迎来新希望

2020-08-01

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

2019年神经肿瘤学会：IL-12治疗复发性胶质母细胞瘤的临床数据

2019-11-26

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

Lancet oncol：瑞戈非尼可提高复发性胶质母细胞瘤患者总体存活率（REGOMA研究）

2018-12-10

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

NEJM：重组脊髓灰质炎病毒治疗复发性胶质母细胞瘤

2018-06-30

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

ASCO2017 ：VEGFR2 单抗用于复发性胶质母细胞瘤

2017-06-08

charl1234571 (审核中...)

前往app查看评论内容

#复发性胶质母细胞瘤#

J Neurooncol：重大突破！基因疗法可使复发性胶质母细胞瘤患者的存活期翻倍

2015-10-07

科室
- - 订阅+
  - 更多科室
工具
服务